Podcasts about Nephrology

It's one of those conditions that has no symptoms during its early stages, meaning that by the time it is diagnosed, it could be very late: chronic kidney diseases, or CKD, has been in the news recently after a Parliamentary Standing Committee tabled a report on this condition in the Rajya Sabha earlier this month, and made a series of 66 recommendations. Significantly, the committee recommended diagnosis methodologies, called for a national CKD screening protocol and a registry, highlighted CKD of unknown etiology in certain States especially among agricultural workers and recommended greater use of peritoneal dialysis. So what is chronic kidney disease, why and how does it take place, what does it to the body, and who needs to be tested and when? Guest: Dr Rajan Ravichandran, Director, Nephrology, MIOT Hospital, Chennai and Chairman, Sapiens Health Foundation Host: Zubeda Hamid Edited by Sharmada Venkatasubramanian Learn more about your ad choices. Visit megaphone.fm/adchoices

Our kidneys do an incredible job filtering our blood every hour of every day. Most of us have two kidneys, and each one has about a million microscopic filters called glomeruli. Unlike the filters in our HVAC system, though, these filters cannot be replaced. But they do their work so well and unobtrusively that most of us don't even think about our kidney function. Although 37 million Americans have kidney trouble, the majority are unaware of their situation. Two tests could reveal how well the kidneys are working. What are they, and how often should you ask about them? At The People's Pharmacy, we strive to bring you up‑to‑date, rigorously researched insights and conversations about health, medicine, wellness and health policies and health systems. While these conversations intend to offer insight and perspective, the content is provided solely for informational and educational purposes. Please consult your healthcare provider before making any changes to your medical care or treatment. How You Can Listen You could listen through your local public radio station or get the live stream at 7 am EST on Saturday, August 8, 2026, through your computer or smart phone (wunc.org). Here is a link so you can find which stations carry our broadcast. If you can't listen to the broadcast, you may wish to hear the podcast later. You can subscribe through your favorite podcast provider, download the mp3 using the link at the bottom of the page, or listen to the stream on this post starting on August 10, 2026. What Are the Two Tests That Reveal Kidney Trouble? Chronic conditions like high blood pressure and diabetes put a strain on the kidneys. They are very common problems that signal the need for kidney function monitoring. Our guest expert, Dr. Samir Parikh, suggests that all of us should know our numbers. One is derived from the level of creatinine in the blood. This is normally part of a basic metabolic panel. Usually, the panel results will include a number for the estimated glomerular filtration rate (EGFR) calculated from the value for blood creatinine. The other crucial test is a urine test for protein. Keeping Kidneys Healthy by Staying Properly Hydrated One of the simplest tactics to keep kidneys healthy is to provide them with enough liquid. We get some fluid from the food we eat, which may be one reason eating fruits and vegetables seems to be good for us. They are full of water! We also need to drink fluid, and plain water is probably the best choice. It would be smart to use thirst as a guideline and make sure to drink when thirsty. We do avoid overdoing water consumption, though, as overloading the kidneys with more fluid than they can handle is dangerous as well. Medicines That Are Hard on the Kidneys We mentioned to Dr. Parikh the experience of an older friend, a devoted runner, who discovered that taking ibuprofen after a run reduced the likelihood of having to get up overnight to urinate. He reminded us and our listeners that nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, naproxen, celecoxib or meloxicam can be hard on the kidneys. That doesn't mean we shouldn't ever take such pain relievers, but perhaps we should try not to make it a habit. When we asked about other medicines that might be tough on the kidneys, he mentioned PPIs. Proton pump inhibitors such as omeprazole (Prilosec) or esomeprazole (Nexium) are often used to treat heartburn or other digestive symptoms. Regular use can put a strain on the kidneys, although the gastroenterologist recommending the medicine might not warn you of that side effect. We asked about environmental toxins and learned that heavy metals such as lead or arsenic can harm the kidneys along with other organs. We should make sure that the food we eat and the water we drink are not contaminated with such compounds. The Possible Benefits of Vitamin B Dr. Parikh has been studying how the kidneys respond to the B vitamin nicotinamide. The preliminary work he and his colleagues have done so far is promising. However, they have not conducted clinical trials to find out whether the vitamin could help people with early kidney disease. Because kidneys work so hard, they need a lot of energy to be produced by the mitochondria in their cells. Those mitochondria need NAD+ (nicotinamide adenine dinucleotide) to function at their best. Providing additional nicotinamide appears to help (Nature Reviews. Nephrology, Feb. 2020).  One to three grams a day appears to be safe and may be beneficial. Medications That Can Promote Kidney Health Some medicines initially developed for other conditions are proving to be helpful in treating kidney disease. In particular, these include diabetes drugs known as SGLT2 inhibitors like dapagliflozin (Farxiga) or empagliflozin (Jardiance). They help slow the decline of kidney function (New England Journal of Medicine, Nov. 4, 2022). GLP-1 agonists may also be familiar because they too are used to treat diabetes. Medications such as semaglutide (Ozempic, Rybelsus, Wegovy) and tirzepatide (Mounjaro, Zepbound) have made headlines as weight loss and diabetes meds, but they also can reduce the risk of kidney failure and other bad outcomes (Lancet. Diabetes & Endocrinology, Jan. 2025). The benefits of these types of drugs should give us hope that we can go from slowing the progression of kidney disease to stopping it in its tracks Taking Care of Your Kidneys We asked Dr. Parikh what we should be doing to care for our kidneys and keep them healthy. He urged us once again to know our numbers: most importantly, the numbers from the two tests we discussed, blood creatinine and urine protein. Other numbers that are important for kidney are our blood pressure and, for those with diabetes, HbA1c. In addition to paying attention to all those numbers, we need to embrace a lifestyle that will help keep them where they belong. That means following a heart-healthy diet, staying physically active and getting adequate sleep. This Week’s Guest Samir M. Parikh, M.D., FASN, is Professor of Internal Medicine and Pharmacology and Chair of Internal Medicine at the University of Texas Southwestern. He holds the Donald W. Seldin Distinguished Chair in Internal Medicine and the Ruth W. and Milton P. Levy, Sr., Chair in Molecular Nephrology. Dr. Samir Parikh, University of Texas Southwestern Listen to the Podcast The podcast of this program will be available Monday, August 10, 2026, after broadcast on Aug. 8. This week's podcast has additional information on a possible role for sodium bicarbonate (baking soda) for kidney function. We also discussed medical silos, and how that leads to gastroenterologists overlooking the kidney risks from PPIs. Also, what should prospective kidney donors consider? You can stream the show from this site and download the podcast for free. Download the mp3, or listen to the podcast on Apple Podcasts or Spotify.

Donate to the Institute: https://givenow.nova.edu/assaf-family-and-community-me-cfs-endowed-fund-campaign/?a=1    In today's episode, Makena Thompson sits down with Dr. Jonas Axelsson, a Swedish physician-scientist specializing in post-viral diseases, to address one of the most urgent questions in ME/CFS and long COVID care: why do standard blood tests keep coming back normal when patients clearly are not well? Dr. Axelsson breaks down what standard diagnostic panels actually measure, why cellular oxidative stress and mitochondrial dysfunction remain invisible to serum chemistry, and why a clean blood test is not the same as a healthy patient. He also outlines two distinct immune patterns he has identified in this patient population, explains why current criteria-based diagnosis is not sensitive enough to distinguish between them, and shares why he believes validated diagnostic tools and mechanism-based treatments are within reach within five years. Learn why your labs can be normal and your illness can still be very real. Tune in to Hope and Help For Fatigue and Chronic Illness. Dr. Jonas Axelsson is a physician specializing in Internal Medicine, Nephrology, Clinical Immunology, and Transfusion Medicine. From 2019 to 2024, he served as Medical Director of the Center for Aphresis and Stem Cell Therapy at Karolinska University Hospital in Stockholm, Sweden. From 2016 to 2022, he was an Associate Professor at Karolinska Institutet in Stockholm, Sweden.   LinkedIn: https://www.linkedin.com/in/jonas-axelsson-484853327    Makena Thompson is a Research Program Manager at the Institute for Neuro-Immune Medicine at Nova Southeastern University.   Haylie Pomroy, Founder and CEO of The Haylie Pomroy Group, is a leading health strategist specializing in metabolism, weight loss, and integrative wellness. With over 25 years of experience, she has worked with top medical institutions and high-profile clients, developing targeted programs and supplements rooted in the "Food is Medicine" philosophy. Inspired by her own autoimmune journey, she combines expertise in nutrition, biochemistry, and patient advocacy to help others reclaim their health. She is a New York Times bestselling author of The Fast Metabolism Diet.   Learn more about Haylie Pomroy's approach to wellness through her website: https://hayliepomroy.com   Instagram: https://www.instagram.com/hayliepomroy  Facebook: https://www.facebook.com/hayliepomroy  YouTube: https://www.youtube.com/@hayliepomroy/videos  LinkedIn: https://www.linkedin.com/in/hayliepomroy/  X: https://x.com/hayliepomroy    Thank you for tuning in to the Hope and Help For Fatigue and Chronic Illness Podcast. Sign up today for our newsletter.

August 4th, 2026 EP:105 UFOs, Spirits, and the Nature of Reality w/Dr. Jonathan Kendall Are UFOs spacecraft from distant planets—or manifestations from another level of reality? Dr. Jonathan Kendall joins ParaTruth: Reborn to discuss his book, The Metaphysics of UFOs, which examines the physical and spiritual nature of UFOs and related unexplained phenomena. Dr. Kendall is a board-certified physician specializing in internal medicine and nephrology. His medical background gives him a unique perspective when considering potential physiological, neurological, and psychological explanations for extraordinary encounters. During this conversation, we explore: The limitations of the extraterrestrial hypothesis UFOs and parallel realities Connections between UFOs and spiritual encounters Abductions and altered states of consciousness Similarities between abductions and near-death experiences UFO encounters and poltergeist activity Cryptids and Men in Black The possible survival of consciousness after death How physics and metaphysics could intersect What these experiences reveal about the nature of reality The question may no longer be whether we are alone in the universe. It may be whether we truly understand the universe—or reality itself. Guest Bio: Jonathan Kendall is a medical doctor, board certified in Internal Medicine and Nephrology, and an author and independent researcher of consciousness, religion, spirituality, and anomalous phenomena. In his writings, he approaches these controversial subjects with the same scientific rigor that has served him in fifteen years of medical practice in Eastern Kentucky. Jonathan has authored two books. His most recent volume, The Metaphysics of UFOs, published by Llewellyn Worldwide, examines the evidence underlying UAPs, ultimately reaching the conclusion that a litany of compelling cases establishes the authenticity of the phenomenon while presenting a challenge to conventional views of reality. In Seeing the Messiah, published by Resource Publications, Jonathan presents the findings of more than a century of psychical research on apparitions, and compares the phenomena to the reported postmortem appearances of the Lubavitcher Rebbe and Jesus Christ. Combining the scrutiny of scholarly resources across the fields of medicine, psychology, theoretical and quantum physics, psychical research, ufology, and theology, Jonathan's primary aim in writing is to generate meaningful conversation regarding some of life's most profound mysteries, including the understanding of spiritual experiences, the question of postmortem survival, and the nature of reality itself.United Public Radio & UFO Paranormal Radio www.uprntalkradio.com

Part One features host Srinath Yadlapalli, MD, in conversation with Lori-Ann Fisher, MD, and Racquel Lowe-Jones, MD, as they discuss the immediate impact of Hurricane Melissa on kidney care and dialysis in Jamaica.

Part One features host Srinath Yadlapalli, MD, in conversation with Lori-Ann Fisher, MD, and Racquel Lowe-Jones, MD, as they discuss the immediate impact of Hurricane Melissa on kidney care and dialysis in Jamaica.

This episode I am reading from Jon Kendall's book 'The Metaphysics of UFOs: Evidential Case Studies on UAPs, Paranormal Phenomena, and Spiritual Experiences' A systematic examination of the physical and spiritual nature of UFOs and other unexplained phenomena. Are UFOs visitors from our universe or parallel realities? Do they come from the same spiritual realm as our dearly departed? How are they connected to cryptids and paranormal activity? Sharing numerous evidential case studies, Jonathan Kendall explores the seemingly irreconcilable physical and spiritual aspects of UFOs/UAPs. The evidence he presents has implications that could lead to revolutionary breakthroughs in the areas of communications, energy use, medicine, interstellar travel, religion, and the nature of reality. This eye-opening book investigates the connection between UFOs and kindred phenomena like monsters, Men in Black, and poltergeists. It also explores the harrowing world of UFO abductions and why the aftereffects are so similar to those of both near-death experiences and encounters with mystical realms. These case studies shatter conventional views of reality and prove that far more is at stake than answering the question, "Are we alone in the universe?" Bio Jonathan Kendall is a medical doctor, board-certified in Internal Medicine and Nephrology, who practices in Eastern Kentucky. Outside of medicine, Jonathan is an author with a passion for exploring the unexplained — from apparitions and consciousness studies to UFOs and paranormal phenomena. Jonathan is the author of Seeing the Messiah and The Metaphysics of UFOs, books that examine extraordinary human experiences through the lenses of science, history, philosophy, and metaphysics. Drawing from both his medical background and years of independent research, Jonathan seeks to thoughtfully examine mysteries that continue to challenge conventional understanding. https://jonathankendallmd.com/ https://www.amazon.com/Metaphysics-UFOs-Evidential-Paranormal-Experiences-ebook/dp/B0FRXLVNHP https://www.pastliveshypnosis.co.uk/https://www.patreon.com/alienufopodcasthttps://simonbown.com/My new book, Aspects of Alien Abduction https://www.amazon.com/dp/B0GRRPCT9YZen AI bit.ly/zenAI_bpp_ufo Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

CME credits: 0.25 Valid until: 14-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/no-patient-with-ckd-left-behind-new-horizons-in-patients-with-ckd-regardless-of-diabetes-status/49260/ A growing body of evidence presented at ERA 2026 is reshaping the conversation around chronic kidney disease management, regardless of diabetes status. In this expert interview, Dr. Katherine Tuttle and Dr. Brendon Neuen examine emerging data on nonsteroidal mineralocorticoid receptor antagonists and discuss how recent findings may expand treatment considerations for patients with chronic kidney disease (CKD), including those without diabetes. Through expert analysis of key studies and a patient perspective, the faculty explore the evolving cardiorenal landscape, practical implications for clinical practice, and opportunities to address persistent unmet needs across the CKD spectrum.=

This episode I'm talking to Jon Kendall about his book 'The Metaphysics of UFOs: Evidential Case Studies on UAPs, Paranormal Phenomena, and Spiritual Experiences' A systematic examination of the physical and spiritual nature of UFOs and other unexplained phenomena. Are UFOs visitors from our universe or parallel realities? Do they come from the same spiritual realm as our dearly departed? How are they connected to cryptids and paranormal activity? Sharing numerous evidential case studies, Jonathan Kendall explores the seemingly irreconcilable physical and spiritual aspects of UFOs/UAPs. The evidence he presents has implications that could lead to revolutionary breakthroughs in the areas of communications, energy use, medicine, interstellar travel, religion, and the nature of reality. This eye-opening book investigates the connection between UFOs and kindred phenomena like monsters, Men in Black, and poltergeists. It also explores the harrowing world of UFO abductions and why the aftereffects are so similar to those of both near-death experiences and encounters with mystical realms. These case studies shatter conventional views of reality and prove that far more is at stake than answering the question, "Are we alone in the universe?" Bio Jonathan Kendall is a medical doctor, board-certified in Internal Medicine and Nephrology, who practices in Eastern Kentucky. Outside of medicine, Jonathan is an author with a passion for exploring the unexplained — from apparitions and consciousness studies to UFOs and paranormal phenomena. Jonathan is the author of Seeing the Messiah and The Metaphysics of UFOs, books that examine extraordinary human experiences through the lenses of science, history, philosophy, and metaphysics. Drawing from both his medical background and years of independent research, Jonathan seeks to thoughtfully examine mysteries that continue to challenge conventional understanding. https://jonathankendallmd.com/ https://www.amazon.com/Metaphysics-UFOs-Evidential-Paranormal-Experiences-ebook/dp/B0FRXLVNHP https://www.pastliveshypnosis.co.uk/https://www.patreon.com/alienufopodcasthttps://simonbown.com/My new book, Aspects of Alien Abduction https://www.amazon.com/dp/B0GRRPCT9YZen AI bit.ly/zenAI_bpp_ufo Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Purespring Therapeutics is a precision nephrology company pioneering first-in-class, targeted genetic therapies designed to preserve kidney function. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Haseeb Ahmad, CEO of Purespring, who discusses transforming the treatment of kidney disease, an area of enormous unmet need, with more than 840 million people worldwide living with chronic kidney disease. Indeed, Purespring's lead programme is the podocyte-targeted gene therapy PS-002, which is for IgA nephropathy (or IgAN). The conversation also touches upon the evolution of the gene therapy landscape more generally, and where next with this type of innovation in the nephrology space. You can listen to episode 267 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

Understanding how values and communication styles differ across cultures is key to succeeding internationally. That’s why training in cross-cultural communication has become commonplace in the international business world. In this session, we’ll look at 6 dimensions of cross-cultural communication and their application to medical scenarios.

Vascular access is the lifeline for people on dialysis. Today we'll cover the different types, how doctors determine the best option, what the surgery and recovery involve, and more! Today we're joined by Dr. Vandana Dua Niyyar, and kidney warrior Brittany Dickerson to discuss vascular access–an important topic that will hopefully help you all listening feel more informed and confident in your care.  In today's episode we heard from:  Vandana Dua Niyyar is Professor of Medicine in the Division of Nephrology and has received the Clinical Distinction of Master Physician at Emory University. Dr. Niyyar is passionate about promoting multidisciplinary collaboration in research and education in the field of vascular access; with the ultimate goal of optimizing access care and processes for dialysis patients. She currently serves as Immediate Past President of the American Society of Diagnostic and Interventional Nephrology (ASDIN). Dr. Niyyar has been recognized for her exemplary clinical and service achievements through various awards including ASDIN Distinguished Service Award in 2019, Emory Nanette Wenger Service Award in 2019, ASN Mid-Career Distinguished Clinical Service Award in 2020, ANIO Clinical Excellence Award in 2021, Emory DOM Outstanding Quality Achievement Award in 2022 and and ASDIN Gerald Beathard Award in recognition of her teaching excellence, scholarly activity, and clinical excellence in 2024. Brittany Dickerson- I am a dedicated mother, motivational speaker, and compassionate life coach living with Polycystic Kidney Disease (PKD). I use my kidney failure battle to educate and help others regarding kidney disease and transplantation. My personal journey has fueled my passion for helping others navigate life's challenges with courage and grace. Through partnership with the National Kidney Foundation, I have had the opportunity to mentor others and to be a guest for the National Kidney Foundation Podcast channel. My dedication to kidney awareness has led me to pursue becoming a National Kidney Foundation Advocate. I use my voice to spread my powerful message of perseverance and hope. My goal is to continue making an impact on individuals facing adversity, offering guidance, support, and being a shining example of strength in the face of hardship.   Additional Resources Vascular Access Guidelines   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.  

We welcome Dr. Kelly Beers, director of Albany Medical Center's Glomerular Disease Center, an interdisciplinary center focused on providing the most up to date treatment for people who have been diagnosed with kidney diseases. Ray Graf hosts.

CME credits: 0.25 Valid until: 18-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/engaging-adult-patients-with-c3gn-shared-decision-making-at-the-crossroads-of-complement-targeted-therapy/54145/ In this Patient-Clinician Connection, Dr. Sayna Norouzi discusses shared decision-making approaches for adult patients with C3 glomerulonephritis (C3GN) receiving complement-targeted therapies. Through a clinical patient vignette, Dr. Norouzi demonstrates patient-centered communication techniques for discussing mechanisms, treatment considerations, and long-term kidney preservation goals in clear, accessible language. Dr. Norouzi reviews key differences among treatment approaches, including mechanism of action, proteinuria reduction, kidney function stabilization, monitoring requirements, route of administration, adherence considerations, and infection risk. The activity also highlights the importance of vaccination review, ongoing monitoring, and aligning treatment decisions with patient priorities and lifestyle factors to support collaborative care planning and patient engagement in C3GN management.=

The FiltrateJoel Topf kidneyboy.bsky.socialSpecial GuestsDr. Samir Parikh, President of the American Society of NephrologyProf. Donal Reddan, President, Irish Nephrology SocietyProf. Catherine GodsonEditing Joel TopfThe Kidney Connection written and performed by Timothy YauShow Notes Tubular SecretionsJoel Topf, the Dublin Port Greenway LinkCatherine Godson: never heard of the Dublin Port GreenwaySamir Parikh: Trinity College Dublin and specifically the Eavan Boland Library, named after the Irish poet. Donal Reddan: Something about rugby

This ASN Kidney Translation Podcast episode covers advances in artificial intelligence: ASN Workgroup on AI (JASN), AI in nephrology education (CJASN), and ethical issues in AI (K360).

Richard Glassock, MD, reflects on decades of advances in kidney diseases and discusses the future of glomerular disease, biomarkers, clinical trials, and prevention with host Andrew Cohen, MD. 

Richard Glassock, MD, reflects on decades of advances in kidney diseases and discusses the future of glomerular disease, biomarkers, clinical trials, and prevention with host Andrew Cohen, MD. 

CME credits: 0.25 Valid until: 21-05-2027 Claim your CME credit at https://reachmd.com/programs/cme/translating-the-latest-kdigo-guidelines-into-practice-iv-iron-therapy-in-patients-with-nondialysis-dependent-ckd/54631/ Iron deficiency and iron-deficiency anemia are related but distinct clinical entities, with iron deficiency often preceding or occurring independently of anemia. In chronic kidney disease (CKD), inflammation-driven iron sequestration and impaired iron availability frequently develop before hemoglobin declines, making hemoglobin-only screening insufficient. Recent updates to the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in CKD highlight the expanded role of IV iron replacement therapy in patients with non–dialysis-dependent CKD, along with the need for proactive iron assessment, earlier identification of iron deficiency phenotypes, and individualized selection of iron replacement strategies to improve long-term patient outcomes. =

Karandeep Singh, MD, speaks with Karin Bergling, MD, and Wisit Cheungpasitporn, MD, about the AI-Powered Kidney Care Network, an ASN Community for those with medical and technical backgrounds interested in AI and its applications in kidney care.

Karandeep Singh, MD, speaks with Karin Bergling, MD, and Wisit Cheungpasitporn, MD, about the AI-Powered Kidney Care Network, an ASN Community for those with medical and technical backgrounds interested in AI and its applications in kidney care.

CME credits: 1.00 Valid until: 15-05-2027 Claim your CME credit at https://reachmd.com/programs/cme/aldosterone-targeted-therapies-uncontrolled-hypertension-chronic-kidney-disease/56405/ Chronic kidney disease (CKD) and high blood pressure (BP) are closely linked and, when not managed appropriately, can lead to serious outcomes such as myocardial infarction, stroke, heart failure, and progression to kidney failure. Pathological excess of aldosterone induces hypertension by forcing the kidneys to excessively retain sodium and water, increasing blood volume, and lowering potassium. Mineralocorticoid receptor antagonists (MRAs), which target the renin-angiotensin-aldosterone system (RAAS), do not fully inhibit the deleterious effects of aldosterone and may increase serum aldosterone concentrations. Highly selective aldosterone synthase inhibitors (ASIs) have emerged as potential alternatives to MRAs; ASIs decrease aldosterone synthesis, providing another strategy to inhibit aldosterone effects without affecting cortisol production.Want to dive deeper into the discussion? Check out Audience Q&A From the Live Symposium in the Related Content section for additional expert insights and practical perspectives on CKD, hypertension, and emerging aldosterone-targeted therapies. =

What is cultural distress? It is a negative response rooted in a cultural conflict where the patient lacks control over their situation. It results in more physiologic effects on the body resulting in allostatic overload. To prevent this, healthcare practitioners must use strategies such as cultural humility to help patients navigate healthcare. Come find the best ways to deliver culturally sensitive care in any setting.

CME credits: 0.25 Valid until: 11-05-2027 Claim your CME credit at https://reachmd.com/programs/cme/new-data-hypercortisolism-prevalence-difficult-to-control-metabolic-conditions/50066/ Recent data from 2024 and 2025 shed light on the prevalence of Cushing syndrome (hypercortisolism) among individuals with hard-to-control metabolic conditions. Now, 2026 brings even more up-to-date insights in this area. Join our expert faculty as they review the latest evidence and discuss its implications for clinical practice. =

In this episode, we explore the major complications of acute kidney injury (AKI) and break down the different modalities of dialysis used in the ICU and inpatient setting.Join us for a high-yield, clinically focused discussion covering AKI complications, and the practical differences between intermittent hemodialysis (HD), peritoneal dialysis (PD), and continuous renal replacement therapy (CRRT).Hosts:Dr. Tanya S. Jain and Dr. Avtandil Kochiashvili, Chief Medical Residents, UConnGuest Expert:Dr. Lalarukh Haider, Assistant Professor of Medicine, Division of Nephrology, UConn Health and Program Director of Nephrology FellowshipAuthor:Dr. Tanya S. Jain, Chief Medical Resident, UConnEdited by:Dr. Avtandil Kochiashvili, Chief Medical Resident, UConnMusic:LoFi Girl by Snoozy Beats | Free Music Archive | License: CC BY

ASN Executive Vice President and Chief Executive Officer Tod Ibrahim explores the history of eGFR with Andrew Levey, MD, Tom Hostetter, MD, and Crystal Gadegbeku, MD. Hear how policy, equity, and care have evolved, and what future assessments demand.

ASN Executive Vice President and Chief Executive Officer Tod Ibrahim explores the history of eGFR with Tom Hostetter, MD, Crystal Gadegbeku, MD, and Andrew Levey, MD, founding director of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI).

ASN Executive Vice President and Chief Executive Officer Tod Ibrahim explores the history of eGFR with Tom Hostetter, MD, Crystal Gadegbeku, MD, and Andrew Levey, MD, founding director of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI).

ASN Executive Vice President and Chief Executive Officer Tod Ibrahim explores the history of eGFR with Andrew Levey, MD, Tom Hostetter, MD, and Crystal Gadegbeku, MD. Hear how policy, equity, and care have evolved, and what future assessments demand.

This session will discuss the rising demand for kidney care, key causes of workforce gaps, and the impact on patient outcomes. It would also highlight practical solutions to strengthen the nephrology nursing workforce.Moderator: Ana Figueiredo Speakers:Rachael WalkerMarques Shek Nam NgGinger ChuLaura Lunardi 

CME credits: 0.25 Valid until: 30-04-2027 Claim your CME credit at https://reachmd.com/programs/cme/navigating-upated-kdigo-clinical-practice-guideline-recommndations-to-maximize-proteinuria-reduction-in-patients-with-igan/26630/ Our experts review updated KDIGO practice guideline recommendations for proteinuria reduction in IgA nephropathy (IgAN) and their implications for clinical care. Drs. Chee Kay Cheung and Claudia Seikrit examine the shift toward lower proteinuria targets (

This ISN i3C podcast brings together leading ISN experts to unpack a new paper tackling one of nephrology's biggest mysteries: chronic kidney disease of unknown origin (CKDu). The discussion explores why identifying the causes of CKDu has been so challenging—highlighting gaps in terminology, study design, and data collection—while questioning whether current research approaches are asking the right questions. Through expert insights and debate, the podcast emphasizes the need for standardized methods, stronger global collaboration, and a shift toward translating research into prevention, especially in low- and middle-income countries. The podcast closes by looking ahead to priority research areas and how the global community can get involved in advancing solutions. Listeners will come away with a deeper, more nuanced understanding of CKDu.Participants: Ben Caplin (UK), ISN i3C Working Group ChairMagdalena Madero (Mexico), ISN i3C Working Group Deputy ChairEranga Wijewickrama (Sri Lanka)Shuchi Anand (United States) 

Guest Dr. Jeffrey Perl joins host Dr. Tushar Chopra to explore strategies to prevent peritoneal dialysis infections, address gaps in practice, review infection trends, and discuss opportunities for progress through collaboration and team-based care.

Guest Dr. Jeffrey Perl joins host Dr. Tushar Chopra to explore strategies to prevent peritoneal dialysis infections, address gaps in practice, review infection trends, and discuss opportunities for progress through collaboration and team-based care.

In this episode of the RCP Medicine Podcast, Professor Jeremy Levy, consultant nephrologist in London, joins Dr Alex Crowe, consultant physician in Liverpool, for an insightful and practical conversation about chronic kidney disease (CKD). Together, they explore why CKD is so common, and often silent. How to distinguish acute from chronic kidney problems, and which investigations matter most.The discussion also highlights the growing importance of cardiorenal metabolic medicine, offering clinicians a clear approach to assessing risk, optimising treatment, and supporting long‑term health. From EGFR trends to SGLT2 inhibitors, from lifestyle change to coding accuracy, this episode provides an essential, up‑to‑date guide for managing CKD in everyday practice.Resources For kidney sake podcast:  Home | ForKidneysSake.com Excellent resources on CKD here from NHS NW London:  Chronic kidney diseaseNICE guidelines: Overview | Chronic kidney disease: assessment and management | Guidance | NICE Hypertension in CKD from UK kidney association  FINAL UKKA NICE-KDIGO commentary December 2022.pdfExercise and Lifestyle in CKD from UK kidney association   Exercise and Lifestyle in CKD clinical practice guideline33_v4_FINAL_0.pdf SGLT2i in CKD  from UK kidney association  Sodium Glucose Co transporter 2 - UK Kidney Association.KDIGO (international) guidelines on CKD management   CKD Evaluation and Management – KDIGOKIDGO prognosis of CKD by Albuminuria Categories: KIDGO 2012 S126American Diabetes Association guidelines including CKD   Volume 48 Issue Supplement_1 | Diabetes Care | American Diabetes AssociationFor Kidneys SakeFor Kidneys Sake is a clinician-led podcast from Imperial College Healthcare NHS Trust and North West London Integrated Care Board, offering practical, evidence-based insight into chronic kidney disease and cardio-renal care. Through short, accessible conversations with experts across primary and secondary care, the series supports shared learning on CKD detection, risk management and integrated patient care. The podcast is for GPs, pharmacists, nurses and multidisciplinary teams, and is relevant for clinicians, patients and anyone interested in improving kidney health.Explore our CPD portfolio by your career stageRCP | Education and professional developmentRCP LinksEducationRCP Social MediaInstagramLinkedInFacebookBlueskyMusic Episode 50 onward - Bensound.com  Episodes 1 - 49 'Impressive Deals' - Nicolai Heidlas Any adverts within this podcast may use computer generated voices

The FiltrateJoel Topf kidneyboy.bsky.socialPedro Teixeira @nephcrit.bsky.socialNayan Arora @captainchloride.bsky.socialAnna Gaddy @annagaddy.bsky.social Swapnil Hiremath @hswapnil.medsky.social and on LinkedInSpecial GuestsIan McCoy, MD @NephroNinja study author and UCSFChi-yuan Hsu Senior author and Chief of the Division of Nephrology at UCSFSamuel Silver Associate Professor at Queens University in CanadaEditingVipin Verghese and Joel TopfShow Notes NephJC Discusion: Dialyze Less, Recover More? AKI's Chance to Get LIBERATE-DManuscript: A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney InjuryThe Liberation From Acute Dialysis (LIBERATE-D) Randomized Clinical Trial JAMA | PubMedBen's pilot study: RAD-AKI Pilot study: Recovery After Dialysis-Requiring Acute Kidney Injury (RAD-AKI) (ClinicalTrials.gov)STARRT-AKI NephJC Editorial in JAMA: A-E-I-O-U and Sometimes Why—Dialysis in Acute Kidney Injury (JAMA)What Is Dialytrauma? (Nephrology Times)How Fragile Are the Results of a Trial? The Fragility Index (PubMedCentral)Shiffl Trial: Daily Hemodialysis and the Outcome of Acute Renal Failure (NEJM)AKIKI: Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit (NEJM)AKIKI2: How Late it was, How Late! (NephJC)Sam Silver's study: Promoting Kidney Recovery After Acute Kidney Injury Receiving Dialysis (Recover-AKI) (ClinicalTrial.Gov)Marie Kondo (Wikipedia)Tubular SecretionsSwap: The smutty dragon novels of novels of Rebecca Yarros (Wikipedia) Specifically The Empyrean seriesAnna: Brisket recipesPedro: The Naked Gun (Wikipedia) with Liam NeesonIan: ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury (PubMed) he really doesn't get Tubular Secretions.Nayan: Tilt: A Novel by Emma Pattee (Amazon)Chi: The Year of Magical Thinking by Joan Didion (Wikipedia) and Innovations in Nephrology (Springer Nature)Sam: Monopoly Super Electronic Banking Board Game (Amazon)Joel: Song Sung Blue (Wikipedia)

Providing primary health care in a war zone presents some extraordinary challenges. This presentation delves into the complex world of healthcare delivery amid conflict and chaos.

Drs. Michael Amirian and Kavita Gupta discuss what patients should know about the prevention and treatment of kidney stones. The panelists provide an overview of the symptoms and risk factors of the condition, including lifestyle choices and diet. They also highlight the crucial information on prevention strategies for better kidney health. For those who may be experiencing kidney stones, the doctors also discuss pain management and recovery steps for passing stones. To schedule with Dr. Michael J. AmirianTo schedule with Dr. Kavita Gupta

Join us for the discussion on the treatment and management of hyperphosphatemia or high phosphorus levels in the blood, a common challenge experienced by people living with chronic kidney disease on dialysis. This episode is supported by Ardelyx.   In this episode we heard from:  Dr. Annabel Biruete is an Assistant Professor and Registered Dietitian in the Department of Nutrition Science at Purdue University and an Adjunct Assistant Professor in the Division of Nephrology at the Indiana University School of Medicine. Her broad clinical interest is nutrition in kidney diseases. Dr. Biruete's research aims to study the effects of nutritional and pharmacological therapies for chronic kidney disease on the gastrointestinal tract and gut microbiome. Additionally, Dr. Biruete is interested in improving outcomes in the Hispanic/LatinX community living with chronic kidney disease, primarily targeting nutritional interventions using language- and culturally-concordant lifestyle educational materials. Melissa Tuff has been living with chronic kidney disease for 30 years. Her journey began in 1996 on her 17th birthday when she “crashed” into dialysis following a misdiagnosed UTI. She was on in-center hemodialysis for 9 and a half years until she received a life-changing kidney transplant that lasted 11 years. In 2016 her kidney rejected and since then, she continued treatment with 4 years of peritoneal dialysis and 6 years of solo home hemodialysis. She utilizes her Social Media pages for digital education & patient empowerment by hosting educational TikTok Live sessions while performing solo home hemodialysis; offering real-time insight into dialysis life and empowering others to take an active role in their treatment. Her goal is to build a support community and reduce the stigma around kidney disease by fostering open, educational, and uplifting conversations online while providing resources and guidance as to how one can live long and well on dialysis. Dr. Jaime Uribarri is a practicing nephrologist and clinical investigator in NYC. He has been in the Icahn School of Medicine at Mount Sinai, NYC, since 1990, where he is currently Professor of Medicine and Director of the Renal Clinic and the Home Dialysis Program at the Mount Sinai Hospital. In parallel with his clinical activities, Dr Uribarri has been very active in clinical investigation for more than 40 years. His main areas of research have been on acid-base and fluid and electrolytes disorders as well as nutrition in chronic kidney disease and diabetic patients. He has published well over 200 peer-reviewed papers, written many chapters in books and edited several books. He has lectured extensively on these research topics in New York City as well as in national and international meetings.   Additional Resources High Phosphorus Mineral and Bone Disorder (CKD-MBD) Secondary Hyperparathyroidism (SHPT) ASN Kidney Health Guidance on Potassium and Phosphorus Food Additives   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

Send us Fan MailDr. Caitlin Carter, Clinical Director of Nephrology at Rady Children's Hospital and associate clinical professor at UC San Diego, joins the podcast to challenge how neonatologists recognize and follow up on acute kidney injury. She explains why creatinine alone is insufficient, how biomarkers like NGAL can detect tubular injury before function declines, and why AKI too often disappears from the discharge summary. She also outlines published consensus guidelines on post NICU nephrology follow-up, with clear thresholds based on gestational age and AKI severity.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

In our March episode, we truly celebrated National Kidney Month with Dr. Kristin Meliambro, an Associate Professor in the Department of Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Meliambro discussed the many vital jobs kidneys perform, the causes and symptoms of kidney disease, and preventive measures that can help keep them healthy. In this month's Key Note, Dr. Meliambro walks us through the latest innovations that are making dialysis – the necessary treatment for those living with Stage 5 kidney disease – more manageable.   The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. Find out where your health stands by making an appointment with your primary care physician. Don't have one? Find one at our Provider Directory: www.1199SEIUBenefits.org/find-a-provider. Visit the Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. Get to know your numbers at www.1199SEIUBenefits.org/healthyhearts. Need support managing chronic conditions such as type 2 diabetes, hypertension or overweight? Learn about our partnerships: visit www.1199SEIUBenefits.org/the-choice-is-yours/ Browse healthy recipes and meal-prep tips at 1199SEIUBenefits.org/food-as-medicine. For additional information and support, visit the National Kidney Foundation website, at Kidney.org, and the American Association of Kidney Patients, at www.aakp.org. For information about kidney donation, visit the Nation Kidney Registry page at KidneyRegistry.com Get inspired by fellow members through our Members' Voices series: 1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on building healthy meals, managing stress and more: 1199SEIUBenefits.org/videos. Visit our YouTube channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: 1199SEIUBenefits.org/wellnessevents. Guest Bio Kristin Meliambro, MD, is an Associate Professor in the Department of Medicine, Division of Nephrology at the Icahn School of Medicine at Mount Sinai. She earned her medical degree from the Icahn School of Medicine at Mount Sinai, and she completed both her internal medicine residency and clinical and research nephrology fellowships at the Mount Sinai Hospital. In addition to treating patients with a wide range of kidney diseases in diverse clinical settings, Dr. Meliambro is an NIH-funded physician-investigator who conducts basic and translational research with a focus on mechanisms of kidney podocyte injury and novel disease therapies. She is the co-Director of the Nephrology Division's Renal Biorepository, which banks biological specimens and collects clinical data from patients starting at the time of kidney biopsy and continuing longitudinally. She also actively participates as a PI and Co-Investigator in clinical trials testing novel agents for glomerular diseases. Dr. Meliambro also has a strong record of research mentorship of Associate Researchers and graduate/medical students in her lab, the majority of whom have been women and from under-represented minorities in science and medicine. Dr. Meliambro sees patients with a variety of kidney diseases, and she has a particular clinical interest in glomerular diseases. Her clinical responsibilities include the care of outpatients at the Mount Sinai Doctors nephrology practice, hemodialysis patients at Central Park Dialysis Center and inpatients at the Mount Sinai Hospital, where she also teaches and supervises nephrology fellows on the inpatient nephrology services.

For people living with kidney disease, clinical trials can offer hope—but not without questions or concerns. Today, we talk with Dr. Nadine Barrett, Glenda Roberts, and Luz Baqueiro about lived experience, community trust, and the power of being asked. In this episode we heard from:  Dr. Nadine J. Barrett is a Professor in the Department of Social Sciences and Health Policy in the Division of Public Health Sciences and the inaugural Senior Associate Dean of Community Engagement and Equity in Research at Wake Forest School of Medicine, she is Associate Director of Community Outreach and Engagement for Wake Forest Comprehensive Cancer Center, the Clinical Translational Science Institute and the Maya Angelou Center for Health Equity. Prior to joining Wake Forest, Dr. Barrett served 13 years in senior leadership roles at Duke University, as the Founding Director of both the Duke Center for Equity in Research and the nationally awarded, Duke Cancer Institute's Office of Health Equity. She is also President of the national Association of Cancer Care Centers, in Washington DC. A medical sociologist by training, Dr. Barrett is a health disparities researcher, expert equity strategist, and a nationally recognized leader in facilitating authentic community, healthcare, and academic partnerships to advance health equity. She develops multi-level interventions to address implicit bias, structural and systemic racism, and inequities that limit access to quality research and trustworthy health care among underserved and marginalized populations. Dr. Barrett brings an equity lens to her work and collaborations to enhance healthcare systems, close the disparities gap in health outcomes, and increase diverse and broad representation in research participation and the research workforce. Glenda Roberts: Prior to joining the Mount Sinai Center for Kidney Disease Innovation as the Director of Communications and Patient Engagement, Glenda V. Roberts was an Information Technology executive with over 35 years of experience with top-caliber corporations, including General Electric, Microsoft and Johnson & Johnson. She was also the Executive Director of the Seattle Transplant House, and the Director of External Relations & Patient Engagement at the University of Washington Center for Dialysis Innovation (CDI) and the Kidney Research Institute (KRI). Before going on dialysis, Glenda managed the progression of her disease for over 40 years using diet and exercise. Since her transplant in 2010, she's completed nine half marathons. Based upon her personal experience with kidney disease, Glenda is a passionate activist for kidney research and patients living with kidney disease. She's involved in myriad patient-centered national and international health care transformation initiatives.  All are focused on addressing patient preferences and improving patient-reported outcomes.   Glenda brings the patient voice to several NIH/NIDDK government and industry research efforts (Kidney Precision Medicine Project, APOLLO), as well as the American Society of Nephrology's Current & Emerging Threats (C-ET) Steering Committee. She's the inaugural co-chair of the Critical Path Institute's Biomarker Data Repository Governance Committee, and a member of the Kidney Health Initiative (KHI) Board of Directors. Additionally, she contributes to the Advisory Boards of LifeCenter Northwest and Home Dialyzors United, and over 15 other industry and academic research advisory committees/boards focused on transplantation, kidney, cardiovascular, and metabolic health. As an ambassador for the National Kidney Foundation, the American Kidney Fund, and the American Association of Kidney Patients, Glenda's advocacy tirelessly advances the voices, needs, and aspirations of the kidney community worldwide. Luz Baqueiro serves as a patient advocate with the National Kidney Foundation (NKF), providing feedback and helping develop new initiatives to better support the Latin American community affected by chronic kidney disease. She also raises awareness of the barriers faced by patients living with renal failure while educating and supporting her community in Georgia. In 2019, Luz was diagnosed with end-stage renal disease (ESRD). With limited resources  in Georgia, she relied on emergency in-hospital dialysis for a year. In August 2021, through self-determination, self-education, and the support of her family and community, she received a kidney transplant.   Additional Resources Clinical Trial Information Hub What is a Clinical Trial? Are Clinical Trials Safe?   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

In this special edition on Obesity as a Chronic Disease our host, Dr. Neil Skolnik will discuss epidemiology, pathophysiology and screening for CKD in People with Diabetes. This special episode is supported by an independent educational grant from Bayer. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Holly Kramer, M.D., Professor of Public Health Sciences and Medicine in the Division of Nephrology and Hypertension at Loyola University Chicago, past-president of the National Kidney Foundation, Editor-in-Chief of the National Kidney Foundation's journal,  Advances in Kidney Disease and Health (AKDH).   Selected references: Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 . The American Diabetes Association's Standards of Care 2026, Diabetes Care 2026;49 (Supplement_1) :S246–S260  

Augusto Cesar Soares dos Santos Junior hosts the latest episode of the Global Kideny Care podcast, and this special episode is part of the offerings for NephMadness 2026. Augusto is joined by Ana Catalina Alvarez Elias: Renal Research Institute, Lili Chan: Mount Sinai, Neil Reza Evans: UC Davis Health, and Kuang-Yu Jen: UC Davis Health, where they discuss the emerging role of Artificial Intelligence in nephrology. AI stands out as a truly transformative force and is reshaping how diseases are diagnosed, how nephrologists interpret complex data, and understand patients. 

This episode includes authors from the recent AJHP theme issue on management of chronic kidney disease as well as pharmacists practicing in a variety of nephrology-related settings. The field of nephrology is evolving with new therapies and payment models, and pharmacists can positively impact patients throughout their continuum of kidney care. The panelists will discuss their impact on nephrology care and visions for the field.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Have you longed to integrate your Christian faith into your patient care—on the mission field abroad, in your work in the US, and during your training? Are you not sure how to do this in a caring, ethical, sensitive, and relevant manner? This “working” session will explore the ethical basis for spiritual care and provide you with professional, timely, and proven practical methods to care for the whole person in the clinical setting. https://www.dropbox.com/scl/fi/qpah9kh1lttg6cm1jjop9/Bob-Mason-Ethics-of-Spiritual-Care-revised.pptx?rlkey=0emve2ja8282nv8xc4uinq1hg&st=9033htwx&dl=0

Dr. Raeeda Gheewala is a double board-certified physician in Internal Medicine and Nephrology with over two decades of clinical experience. She has dedicated her career to advancing kidney health and exploring its vital connection to physical performance. As one of the few specialists in Sports Nephrology, Dr. Gheewala blends her expertise in kidney medicine with her passion for sports and wellness—helping athletes optimize hydration, recovery, and kidney function for peak performance. Beyond her clinical work, she advocates for prevention and proactive health, empowering individuals to protect their kidneys through informed lifestyle choices. Her patient-centered, holistic approach has earned her respect among colleagues and athletes alike. Dr. Gheewala continues to educate and inspire through her practice, speaking engagements, and online platform, where she shares evidence-based insights on how balanced living supports kidney and overall health. Some of the topics we discussed were: High-protein diets and supplementsHow athletes can balance performance nutrition with kidney preservationHow much protein to consume based on your level of activityVariability in protein intake per dayMyths about the safety of creatine supplements Advice for physicians or entrepreneurs who are interested in building their own practices in unique areasWhat athletes should know about hydration, heat illness, and kidney function Preventative measures to keep in mind for staying active in the summer heat And more! Interested in learning more about my telehealth direct specialty care practice? At AmazVita Wellness MD, I help patients optimize weight and metabolic health, harmonize hormones in peri/menopause, and enhance wellness and vitality. Accepting new patients now.amazvitamd@gmail.com or text (530) 332-8573 Learn more about me or schedule a FREE coaching call:https://www.joyfulsuccessliving.com/ Join the Voices of Women Physicians Facebook Group:https://www.facebook.com/groups/190596326343825/ Connect with Dr. Gheewala: Website: sportsnephrology.com Instagram: @thekidneyqueenmd TikTok: @sportskidneycoach Youtube: https://www.youtube.com/@KidneyQueenMD 

I know 2026 feels like it ihas been here for months, but only a few weeks ago we were celebrating the nephrology accomplishments of 2025. The New Filtrate came together to review the year.The FiltrateJoel Topf‍ ‍@kidneyboy.bsky.social‬ (COI)Swapnil Hiremath @hswapnil.medsky.social and on LinkedIn Editor in Chief of Kidney International Case ReportsAnna Gaddy (@AnnaGaddy) Winner of NephJC Rookie of the Year 2020Nayan Arora (@CaptainChloride.bsky.social)AC (@medpeedskidneys.bsky.social)Vipin Verghese (@vipvargh.bsky.social) co-winner of NephJC Engaged Scientist of the Year in 2021Brian Rifkin (@brianrifkin.bsky.social) Co-Editor in Chief NephJC. Winner of NephJC Rookie of the Year 2021Cristina Popa (@NephroSeeker) Co-Editor in Chief NephJC. Wwinner of NephJC Rookie of the Year 2022 and MVP 2023Editing and Show Notes byAnna Gaddy and Joel TopfThe Kidney Connection written and performed by Tim YauShow NotesTop Stories in Nephrology 2025 (NephJC)First Top sories in Nephrology 2010! (Renal Fellow Network)Links to all of the Top Stories in Nephrology, hosted on NephJC since 2017 (NephJC)1. IgA NephropathyVISIONARY: Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial (NEJM)ORIGIN 3: A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy (NEJM)APPLAUSE-IgA Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy (NEJM)Aliza M. Thompson, MD, MS (ASN) 2. Lupus NephritisREGENCY: Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis (NEJM)3. Nobel prize winner and peripheral immune tolerance4. Xenotransplantation5. GLP1ra RevolutionRemodel REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide (Kidney International)SURPASS-CVOT Tirzepatide vs. Dulaglutide Is Associated with Reduced Major Kidney Events in Patients with Type 2 Diabetes, CVD, and Very High-Risk Kidney Diseases (Kidney Week abstract in JASN)Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford (KFF survey)6. GDMT implementation in CKD: lessons learnt from CONFIDENCE and MIRO-CKDConfidence Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (NEJM)MIRO-CKD Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial (The Lancet)7. Flozin Meta analysisSMART-C. SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria. A Meta-Analysis (JAMA)SMART-C. Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria. A Meta-Analysis (JAMA)8. Paradigm Shift: Aiming for CKD Remission9. Fish Oil and DialysisPISCES Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis (NEJM)10. Decline in Dialysis Patients in the United StatesUSRD 2025 Annual Data Report (USRDS)Tubular SecretionSwapnil Hiremath Alien Earth on FX Hulu (Wikipedia)AC A Christmas Carol by Charles Dickens (Wikipedia) and The Muppet Christmas Carol (Wikipedia)Anna Monty Don (Wikipedia)Nayan Back Street Boys at The Sphere (Wikipedia)Brian Marty Supreme (Wikipedia)Cristina The Yellow Tie (Wikipedia)Vipin Stranger Things, good for a four year old? (Wikipedia)Joel Crash Course: The Universe with Katie Mack and John Green (Apple PodCasts)

Dr. Raeeda Gheewala is a double board-certified physician in Internal Medicine and Nephrology with over two decades of clinical experience. She has dedicated her career to advancing kidney health and exploring its vital connection to physical performance. As one of the few specialists in Sports Nephrology, Dr. Gheewala blends her expertise in kidney medicine with her passion for sports and wellness—helping athletes optimize hydration, recovery, and kidney function for peak performance. Beyond her clinical work, she advocates for prevention and proactive health, empowering individuals to protect their kidneys through informed lifestyle choices. Her patient-centered, holistic approach has earned her respect among colleagues and athletes alike. Dr. Gheewala continues to educate and inspire through her practice, speaking engagements, and online platform, where she shares evidence-based insights on how balanced living supports kidney and overall health. Some of the topics we discussed were:Why sports nephrology is importantHow Dr. Gheewala's sports nephrology practice addresses the unique kidney health risks faced by athletesThe best strategies for pain management in athletes with kidney concernsHow to determine how hydrated you areHydrating with electrolyte rich fluids, not just water, during a marathonEarly red flags that kidneys might be under stressHow athletes or active adults returning from injury can protect their kidneys during recoveryOne daily habit that supports both kidney health and pain-free performanceHow best to hydrate depending on level of kidney functioning And more! Interested in learning more about my telehealth direct specialty care practice? At AmazVita Wellness MD, I help patients optimize weight and metabolic health, harmonize hormones in peri/menopause, and enhance wellness and vitality. Accepting new patients now.amazvitamd@gmail.com or text (530) 332-8573 Learn more about me or schedule a FREE coaching call:https://www.joyfulsuccessliving.com/ Join the Voices of Women Physicians Facebook Group:https://www.facebook.com/groups/190596326343825/ Connect with Dr. Gheewala:Website: sportsnephrology.com Instagram: @thekidneyqueenmd TikTok: @sportskidneycoach Youtube: https://www.youtube.com/@KidneyQueenMD 

Is dialysis nephrology's greatest achievement or its original sin? In this Kidney Commute: Pit Stop episode, host Dr. Osama El Shamy, welcomes Dr. Andrew Cohen, to discuss a provocative question that challenges how the field of nephrology has evolved. Drawing from Dr. Cohen's recent AJKD publication, the conversation explores key historical milestones, including early innovations, the 1972 Medicare amendment, and the rise of corporatized dialysis care. Together, they examine how these forces have shaped trainee perceptions, workforce recruitment, and the identity of nephrology today. The episode concludes with a forward-looking discussion on how the field can refocus priorities, embrace innovation, and chart a more balanced path beyond dialysis-centered care. AJKD Article: https://www.ajkd.org/article/S0272-6386(25)00711-5/abstract